Inactive Instrument
Company Endologix, Inc. Nasdaq
Stocks
US29266S1069
Medical Equipment, Supplies & Distribution
Business description: Endologix, Inc.

Sales by Activity: Endologix, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
Development, Manufacture, Marketing and Sale of EVAR and EVAS Products | 143M |
Geographical breakdown of sales: Endologix, Inc.
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States (U.S.) | 95.32M |
International | 48.05M |
Executive Committee: Endologix, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
John Liddicoat
CEO | Chief Executive Officer | 62 | 2025-01-06 |
Cindy Pinto
DFI | Director of Finance/CFO | - | 2014-08-31 |
Graham Phillips
COO | Chief Operating Officer | - | 2024-06-17 |
Matt Poole
CTO | Chief Tech/Sci/R&D Officer | - | 2023-01-31 |
Hara Jorge
SAM | Sales & Marketing | - | 2025-03-31 |
Composition of the Board of Directors: Endologix, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | 44 | 2020-10-31 | |
Avi Kometz
BRD | Director/Board Member | - | - |
| Director/Board Member | - | - | |
Lucas Buchanan
BRD | Director/Board Member | 48 | 2023-08-23 |
John Liddicoat
BRD | Director/Board Member | 62 | 2025-01-06 |
Arthur Taylor
BRD | Director/Board Member | 69 | 2024-01-24 |
Scott Ward
BRD | Director/Board Member | 66 | 2024-01-08 |
R. Huennekens
BRD | Director/Board Member | 61 | 2025-07-08 |
Company details: Endologix, Inc.

Medical Devices & Implants
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.84% | -3.74% | -27.56% | +1.79% | 169B | ||
| -0.07% | -2.55% | -11.59% | +12.86% | 110B | ||
| +0.90% | +1.13% | -25.66% | +3.60% | 106B | ||
| -1.24% | -0.76% | -49.04% | -12.75% | 73.87B | ||
| -0.24% | +0.69% | +2.08% | +71.44% | 58.98B | ||
| -0.86% | +2.96% | +13.57% | +59.50% | 51.28B | ||
| -0.71% | -3.82% | -8.68% | -31.71% | 48.16B | ||
| +0.12% | -0.17% | -17.87% | +21.91% | 40.84B | ||
| -1.01% | -1.45% | +27.31% | -6.14% | 32.21B | ||
| Average | -0.25% | -0.86% | -10.83% | +13.39% | 76.69B | |
| Weighted average by Cap. | +0.03% | -1.30% | -16.97% | +11.00% |

















